DXCM News and Press, DexCom Inc. From 12/11/23

2023-12-11 06:44:02 ET Summary The S&P 500 reached 4,600 for the first time since March 2022. The current bull plateau is strong enough to avoid a recession but sluggish enough for the plateau to last for at least 3 years. Cash cows on the bull plateau are helping instant ...

2023-12-06 11:38:31 ET More on S&P 500 Index: The November Labor Report - Bad News Will Be Bad News For Stocks Markets Catch Collective Breath The December Fed Meeting: What To Expect And How To Trade It Buy-rated laggards with out-of-consensus estimates ...

With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems 3,4 The clinically meaningful health outcomes that result from using the t:slim X2 insulin pump with...

2023-12-03 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-26 22:07:39 ET Summary The article discusses the factors that have led to the undervaluation of the MedTech sector, including the rise in interest rates, opposition to corporate acquisitions by the FTC, and the impact of GLP-1-based treatments. I defend the importance of M...

2023-11-20 06:03:00 ET Novo Nordisk 's (NYSE: NVO) Ozempic is indicated to treat diabetes, and its wild success and household name is making a few cardiometabolic device companies rather nervous. With a powerful tool to manage blood glucose levels in hand, patients may not have as m...

2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...

2023-11-19 09:00:00 ET Last year, tech giant Amazon (NASDAQ: AMZN) and medical device specialist DexCom (NASDAQ: DXCM) were among the several high-profile companies to conduct stock splits. This move attracted plenty of attention from investors and analysts. As we know, ...

2023-11-17 10:07:00 ET With shares of DexCom (NASDAQ: DXCM) falling 11% this year amid a steadily rising market, one might think that the medical device maker's growth potential is ebbing compared to its former glory. But given its big ambitions to sell its medical devices globally,...

2023-11-17 09:20:22 ET Summary Medtronic plc will announce its fiscal year 2024 Q2 earnings Tuesday 21st November. Analysts expect Q2 revenues of ~$7.9bn, normalized EPS of $1.18, and GAAP EPS of $0.81. Key areas of focus include the impact of U.S.-China relations, supply chai...